Sort by
Refine Your Search
-
. Studies incorporate approaches in both primary human immune cells and in vivo mouse intestinal model systems. Education and experience: Candidates must have a PhD or equivalent degree with a strong
-
author original science at the intersection of health decision science, pharmacoepidemiology, and clinical oncology and hematology, (2) mentor talented trainees (students, residents, and clinical fellows
-
biochemistry, molecular biology, (genetics, or bacteriology) * have first-author publication(s) in peer-reviewed journals * be highly self-motivated. Ideal candidates will want to: * conduct original
-
skills; access to social-emotional learning in school; and the role of emotionally supportive adult caregivers (parents, educators, coaches, and mentors). The postdoctoral associate’s primary
-
recruiting for a postdoctoral associate position starting July 1, 2025. PRIME is a research and treatment clinic with the primary mission to study the course of symptoms that are sometimes prodromal
-
Organization: Yale School of Public Health Department: Biostatistics Primary Location: New Haven, CT Education Level: PhD Shift: Days, 40 hours/week Work Modality: Flexible, hybrid working arrangements could be
-
. Opportunities for presentations at local, regional, and national meetings, manuscript writing, grant preparation, and professional development. Qualifications: MD, PhD, PharmD, or equivalent degree. Background in
-
. Under the direction of the Principal Investigator, the ideal candidate is expected to lead several efforts, including working with the team to develop, discover and apply novel machine learning/natural
-
practices with native trees. To support this initiative, ELTI has received an initial seed grant from Yale Planetary Solutions (YPS). The funding will support three primary activities: (1) establishing a
-
findings. Training/Mentoring/Education The postdoctoral associate will work directly with Principal Investigators within the Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²), including Dr